Skip to main content

Table 1 Summary of 15 reports of hemophagocytic syndrome after liver transplantation

From: Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature

First author No. Age (years) Sex Donor type Diagnosis Onset Causes Treatment Prognosis
(POD) G-CSF IVIg Steroid Dialysis Chemotherapy
Chisuwa (8) 1 9 mo F Living Biliary atresia 15 Unknown + + PE Etoposide Died
2 11 mo M Living Biliary atresia 134 EBV + + Died
Hardikar (13) 3 26 mo M Deceased Acute liver failure 15 CMV + + Alive
George (9) 4 10 M Deceased Acute liver failure 6 years EBV + + Etoposide Alive
Taniai (12) 5 37 F Living Unknown 11 Unknown + + PE, CHDF Died
Karasu (10) 6 38 M Living HBV/HDV 124 Unknown + + PE Alive
Akamatsu (14) 7 48 F Living LC/HCV 50 HCV + Died
Dharancy (15) 8 49 F Deceased polycystic liver/kidney 12 HHV6 Died
Akamatsu (14) 9 49 F Living PBC 315 CMV + + PE Died
Soyama (3) 10 57 M Living LC/HCV/HCC 32 CMV/HCC + + + Died
Akamatsu (14) 11 59 M Living LC/HCV 138 Aspergillus Died
Soyama (3) 12 63 M Living LC/HCV/HCC 81 Unknown + + + Died
Llado (11) 13 63 M Deceased Autoimmune hepatitis NA Unknown + + Died
Yoshizumi (1) 14 63 M Living PBC 13 SFSS + + + Alive
Present case 15 63 F Living HBV 7 SFSS + + + CHDF Died
  1. CHDF continuous hemodiafiltration, CMV cytomegalovirus, EBV Epstein-Barr virus, G-CSF granulocyte-colony stimulating factor, HBV hepatitis B virus, HCV hepatitis C virus, HCC hepatocellular carcinoma, HDV hepatitis D virus, HHV6 human herpesvirus 6, IVIg intravenous immunoglobulin, LC liver cirrhosis, mo months, NA not available, PBC primary biliary cholangitis, PE plasma exchange, POD postoperative day, SFSS small-for-size syndrome